Involvement of N‐methyl‐D‐aspartate receptor subunits in zinc‐mediated modification of CA1 long‐term potentiation in the developing hippocampus

Abstract

Zinc is an endogenous N-methyl-D-aspartate (NMDA) receptor blocker. It is possible that zinc-mediated modification of hippocampal CA1 long-term potentiation (LTP) is linked to the expression of NMDA receptor subunits, which varies with postnatal development. In the present study, the effect of ZnCl(2) and CaEDTA, a membrane-impermeable zinc chelator, on CA1 LTP induction was examined in hippocampal slices from immature (3-week-old) and young (6-week-old) rats. Tetanus (10-100 Hz, 1 sec)-induced CA1 LTP was more greatly enhanced in 3-week-old rats. CA1 LTP was inhibited in the presence of 2-amino-5-phosphonovalerate (APV), an NMDA receptor antagonist, and CaEDTA in 3-week-old rats, as in the case of 6-week-old rats reported previously. In 3-week-old rats, on the other hand, 5 μM ZnCl(2) attenuated NMDA receptor-mediated EPSPs more than in 6-week-old rats and significantly attenuated CA1 LTP. Moreover, 5 μM ZnCl(2) significantly attenuated CA1 LTP in the presence of (2R,4S)-4-(3-phosphonopropyl)-2-piperidinecarboxylic acid (PPPA), an NR2A antagonist, in 3-week-old rats, but not that in the presence of ifenprodil, an NR2B antagonist, suggesting that zinc-mediated attenuation of CA1 LTP is associated with the preferential expression of NR2B subunit in 3-week-old rats. In 6-week-old rats, however, 5 μM ZnCl(2) significantly potentiated CA1 LTP and also CA1 LTP in the presence of PPPA. The present study demonstrates that endogenous zinc may participate in the induction of CA1 LTP. It is likely that the changes in expression of NMDA receptor subunits are involved in the zinc-mediated modification of CA1 LTP in the developing hippocampus.

Zinc Neurotoxicity and the Pathogenesis of Vascular-Type Dementia: Involvement of Calcium Dyshomeostasis and Carnosine

“…Zn inhibits the NMDA-type channels, and attenuate glutamate-induced neuronal death by blocking the increase of [Ca 2+ ] i . Moreover, low concentration of Zn reportedly enhanced LTP [93]. In this condition, Zn acts as an endogenous modulator of neuronal excitability and neuronal plasticity, and is implicated in the memory formation and in the information processing [94].…”

A pilot clinical phase II trial MemSID: Acute and durable changes of red blood cells of sickle cell disease patients on memantine treatment

“…In India, zinc sulfate or acetate was provided to SCD patients for replenishment of depleted zinc stores [42][43][44]. This therapeutic approach resulted in prevention of dehydration of RBCs [46,47] and in cardiac muscle [31]. Myocardial NMDARs resemble the erythroid receptors in their subunit composition [31].…”

The Zinc Ion Chelating Agent TPEN Attenuates Neuronal Death/apoptosis Caused by Hypoxia/ischemia Via Mediating the Pathophysiological Cascade Including Excitotoxicity, Oxidative Stress, and Inflammation

“…It is stored in presynaptic vesicles together with glutamate and released into the extracellular space in an activity‐dependent manner . Released Zn 2+ functions as a neurotransmitter or a neuromodulator and plays important and wide‐spectrum physiological roles in cognition , brain development , sensory , behavior, and emotion . On the other hand, Zn 2+ is implicated directly or indirectly in the pathogenesis of numerous neurological diseases including Alzheimer's disease, amyotrophic lateral sclerosis, depression, epilepsy, ischemia, and schizophrenia .…”